CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Prometheus S.r.l. creates 3D human-like tissues for regenerative medicine and drug testing using living human cells. Their technology aims to improve the accuracy of preclinical drug tests and reduce costs for pharmaceutical companies, with a focus on developing a 3D Lymph Node model for cancer immunotherapy testing.
Prometheus S.r.l. develops and markets 3D human like tissues for regenerative medicine and pharmacological tests. A proprietary 3D Bioprinting Technology enables Prometheus to make use of human living cells as ink, to building up 3D tissues equal for structure and features to the human ones.
The human living cells are printed by a strictly controlled process with high resolution, remaining alive during the entire printing process and for a long time beyond.
The cutting edge new tissues satisfy t…
PROMETHEUS S.R.L.
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
